PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Social Science and Medicine

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Social Science and Medicine has 1 tracked paper indexed in Blossom (2019) from 2 authors, most often covering LSD, across Headache Disorders (Cluster & Migraine) and Chronic Pain.

Published Papers

Open Accessindividual

Collective self-experimentation in patient-led research: How online health communities foster innovation

This digital ethnographic study investigates how online health communities use self-experimentation to determine their treatment protocols by examining the case study of clusterbusters, a platform that came into being when a self-experimenter reported that LSD had prevented his usual cluster headache cycles on an internet forum. This example typifies how a rare disease being responded to with an even rarer form of intervention is cultivated through the collective experimentation of patient communities embedded in social networks who engage in collective forms of knowledge production.

Published
October 1, 2019
Journal
Social Science and Medicine
Authors
Kempner, J., Bailey, J.

Quick Facts

Papers Indexed
1
h-Index
296
Open Access
No
Publisher
Elsevier
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.